Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 16710316)

1.

Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.

Raskind MA, Burke BL, Crites NJ, Tapp AM, Rasmussen DD.

Neuropsychopharmacology. 2007 Feb;32(2):284-8. Epub 2006 May 10.

2.

Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat.

Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, Rasmussen DD.

Endocrinology. 2000 Feb;141(2):487-97.

PMID:
10650927
3.

The once-daily human GLP-1 analog, liraglutide, reduces olanzapine-induced weight gain and glucose intolerance.

Lykkegaard K, Larsen PJ, Vrang N, Bock C, Bock T, Knudsen LB.

Schizophr Res. 2008 Aug;103(1-3):94-103. doi: 10.1016/j.schres.2008.05.011. Epub 2008 Jun 25.

PMID:
18579346
4.

Investigation into the influence of a high fat diet on antipsychotic-induced weight gain in female rats.

Fell MJ, Neill JC, Anjum N, Peltola LM, Marshall KM.

J Psychopharmacol. 2008 Mar;22(2):182-6. doi: 10.1177/0269881107082287. Epub 2008 Feb 28.

PMID:
18308803
5.

The efficacy of mifepristone in the reduction and prevention of olanzapine-induced weight gain in rats.

Beebe KL, Block T, Debattista C, Blasey C, Belanoff JK.

Behav Brain Res. 2006 Aug 10;171(2):225-9. Epub 2006 Jun 19.

PMID:
16782211
6.

The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats.

Fell MJ, Anjum N, Dickinson K, Marshall KM, Peltola LM, Vickers S, Cheetham S, Neill JC.

Psychopharmacology (Berl). 2007 Oct;194(2):221-31. Epub 2007 Jun 21.

PMID:
17581744
7.

Short- and long-term effects of antipsychotic drug treatment on weight gain and H1 receptor expression.

Han M, Deng C, Burne TH, Newell KA, Huang XF.

Psychoneuroendocrinology. 2008 Jun;33(5):569-80. doi: 10.1016/j.psyneuen.2008.01.018. Epub 2008 Mar 20.

PMID:
18358632
8.

Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.

Deng C, Lian J, Pai N, Huang XF.

J Psychopharmacol. 2012 Sep;26(9):1271-9. doi: 10.1177/0269881112449396. Epub 2012 Jun 13.

PMID:
22695490
9.

Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain.

Cooper GD, Harrold JA, Halford JC, Goudie AJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Feb 15;32(2):428-36. Epub 2007 Sep 22.

PMID:
17933447
10.

Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects.

Girault EM, Guigas B, Alkemade A, Foppen E, Ackermans MT, la Fleur SE, Fliers E, Kalsbeek A.

Naunyn Schmiedebergs Arch Pharmacol. 2014 Feb;387(2):185-95. doi: 10.1007/s00210-013-0933-5. Epub 2013 Nov 5.

PMID:
24190543
11.

Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain.

Weston-Green K, Huang XF, Deng C.

PLoS One. 2012;7(3):e33548. doi: 10.1371/journal.pone.0033548. Epub 2012 Mar 16.

12.

Inhibition of olanzapine-induced weight gain by the retinoid analog AM-80.

Richards M, Chiba S, Ninomiya M, Wakabayasi C, Kunugi H.

Pharmacopsychiatry. 2013 Nov;46(7):267-73. doi: 10.1055/s-0033-1354406. Epub 2013 Oct 8.

PMID:
24105080
13.

Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine.

Davoodi N, Kalinichev M, Korneev SA, Clifton PG.

Psychopharmacology (Berl). 2009 May;203(4):693-702. doi: 10.1007/s00213-008-1415-1. Epub 2008 Dec 4.

PMID:
19052729
14.

Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats.

Weston-Green K, Huang XF, Deng C.

Behav Brain Res. 2011 Mar 1;217(2):337-46. doi: 10.1016/j.bbr.2010.10.039. Epub 2010 Nov 4.

PMID:
21056063
15.

Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats.

Fell MJ, Marshall KM, Williams J, Neill JC.

J Psychopharmacol. 2004 Jun;18(2):149-55.

PMID:
15260902
16.

Chronic administration of olanzapine induces metabolic and food intake alterations: a mouse model of the atypical antipsychotic-associated adverse effects.

Coccurello R, Caprioli A, Ghirardi O, Conti R, Ciani B, Daniele S, Bartolomucci A, Moles A.

Psychopharmacology (Berl). 2006 Jul;186(4):561-71. Epub 2006 May 13.

PMID:
16758241
17.

Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways.

Lian J, Huang XF, Pai N, Deng C.

Psychoneuroendocrinology. 2014 Oct;48:77-86. doi: 10.1016/j.psyneuen.2014.06.010. Epub 2014 Jun 18.

PMID:
24992721
18.

Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine.

Zugno AI, Barcelos M, Oliveira Ld, Canever L, Luca RD, Fraga DB, Matos MP, Rezin GT, Scaini G, B├║rigo M, Streck EL, Quevedo J.

Rev Bras Psiquiatr. 2012 Jun;34(2):168-75.

19.

Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat.

Davey KJ, Cotter PD, O'Sullivan O, Crispie F, Dinan TG, Cryan JF, O'Mahony SM.

Transl Psychiatry. 2013 Oct 1;3:e309. doi: 10.1038/tp.2013.83.

20.

Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.

Albaugh VL, Henry CR, Bello NT, Hajnal A, Lynch SL, Halle B, Lynch CJ.

Obesity (Silver Spring). 2006 Jan;14(1):36-51.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk